Coldstream Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Buy |
1,918
+203
| +12% | +$30.8K | ﹤0.01% | 900 |
|
|
2025
Q1 | $258K | Buy |
1,715
+347
| +25% | +$52.2K | 0.01% | 877 |
|
|
2024
Q4 | $253K | Sell |
1,368
-439
| -24% | -$81K | 0.01% | 912 |
|
|
2024
Q3 | $356K | Sell |
1,807
-86
| -5% | -$17K | 0.01% | 748 |
|
|
2024
Q2 | $391K | Sell |
1,893
-5
| -0.3% | -$1.03K | 0.01% | 655 |
|
|
2024
Q1 | $514K | Buy |
1,898
+130
| +7% | +$35.2K | 0.01% | 542 |
|
|
2023
Q4 | $418K | Buy |
+1,768
| New | +$418K | 0.01% | 575 |
|
|
2023
Q3 | – | Sell |
-1,087
| Closed | -$229K | – | 809 |
|
|
2023
Q2 | $229K | Sell |
1,087
-114
| -9% | -$24K | 0.01% | 731 |
|
|
2023
Q1 | $242K | Sell |
1,201
-358
| -23% | -$72.3K | 0.01% | 709 |
|
|
2022
Q4 | $340K | Buy |
+1,559
| New | +$340K | 0.01% | 560 |
|
|
2022
Q2 | $233K | Buy |
1,089
+57
| +6% | +$12.2K | 0.01% | 671 |
|
|
2022
Q1 | $293K | Sell |
1,032
-5
| -0.5% | -$1.42K | 0.01% | 572 |
|
|
2021
Q4 | $391K | Sell |
1,037
-42
| -4% | -$15.8K | 0.01% | 513 |
|
|
2021
Q3 | $244K | Sell |
1,079
-48
| -4% | -$10.9K | 0.01% | 346 |
|
|
2021
Q2 | $417K | Buy |
1,127
+49
| +5% | +$18.1K | 0.02% | 307 |
|
|
2021
Q1 | $312K | Buy |
1,078
+14
| +1% | +$4.05K | 0.02% | 310 |
|
|
2020
Q4 | $266K | Buy |
1,064
+12
| +1% | +$3K | 0.02% | 318 |
|
|
2020
Q3 | $238K | Buy |
+1,052
| New | +$238K | 0.02% | 272 |
|